Livanova learned that an unauthorized party obtained patient data, including Social Security numbers and health conditions, during last year’s attack.

Nearly 2.2 million devices are affected by the recall. Fresenius Medical Care will not have to remove products due to the issue.

New mitral and tricuspid valve treatments are attracting strong demand, but analysts said transcatheter aortic valve replacement sales were shy of expectations.

Philips, Illumina, Insulet and Exact Sciences have all gained new CFOs in recent weeks.

Exo sees the new capabilities as especially helpful for healthcare providers in rural and under-resourced settings.

After a 2023 inspection, the FDA found three unreported field corrections related to CT machines and 19 other recalls of radiology devices.

Intended to preserve resources, the layoffs come weeks after Freenome released study data on its blood test for colorectal cancer that fell short of competitors’ results.

China’s procurement market for medical devices has gradually become more closed for European and foreign companies, the European Commission alleges.

CEO Mike Mahoney would not provide specific sales numbers for the device, but hyped the pulsed field ablation system as the “most transformational product” he’s seen in his time with the company.

Pavlovic, who was a partner at the law firm Manatt, Phelps & Phillips before joining Medtronic, will gain a new title, but her role will stay the same.

The FDA’s recall notice sheds light on the impact to patients weeks after the company told customers it would pull Nimbus pumps from the market.

J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.